Independent Director · AGIOS PHARMACEUTICALS, INC. (AGIO)

Chair, Science and Technology Committee

David Scadden director compensation at Agios Pharmaceuticals: $470K

Fiscal year 2025 director compensation for David Scadden at AGIOS PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get David Scadden’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track David Scadden and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

AGIOS PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held
In US dollars, as AGIOS PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$99,968$299,689$0$469,657
FY2022$67,500$89,997$269,800$0$427,297
FY2021$65,000$89,965$269,983$0$424,947

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AGIOS PHARMACEUTICALS, INC. DEF 14A filed April 24, 2026, accession 0001193125-26-177086, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AGIOS PHARMACEUTICALS, INC. filed document, accession 0001193125-26-177086. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the AGIOS PHARMACEUTICALS Board Governance Report

$469,657 David Scadden, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

AGIOS PHARMACEUTICALS pays directors a $50,000 cash retainer and $400,000 in RSUs/Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Science and Technology (Chair)

The rest of the AGIOS PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Brian GoffDirector—
Catherine Owen AdamsIndependent Director$458,407
Cynthia SmithIndependent Director$467,157
Jacqualyn A. FouseIndependent Director$492,157
Jay BackstromIndependent Director$657,149
Jeffrey CapelloIndependent Director$469,657
Kaye FosterLead Independent Director$498,407
Maykin HoIndependent Director$464,657
Rahul BallalIndependent Director$467,157

The full AGIOS PHARMACEUTICALS compensation record

free company brief

This page is one director within AGIOS PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Order AGIO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report